202 related articles for article (PubMed ID: 25786714)
1. Comparison of systemic mycophenolate mofetil with topical clobetasol in lichen planopilaris: a parallel-group, assessor- and analyst-blinded, randomized controlled trial.
Lajevardi V; Ghodsi SZ; Goodarzi A; Hejazi P; Azizpour A; Beygi S
Am J Clin Dermatol; 2015 Aug; 16(4):303-311. PubMed ID: 25786714
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety, tolerability, and satisfaction of N-acetylcysteine and pentoxifylline in lichen planopilaris patients under treatment with topical clobetasol: A triple arm blinded randomized controlled trial.
Ahmadi Kahjoogh H; Yazdanian N; Behrangi E; Roohaninasab M; Hejazi P; Goodarzi A
Dermatol Ther; 2022 Aug; 35(8):e15639. PubMed ID: 35703373
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of mycophenolate mofetil for lichen planopilaris.
Cho BK; Sah D; Chwalek J; Roseborough I; Ochoa B; Chiang C; Price VH
J Am Acad Dermatol; 2010 Mar; 62(3):393-7. PubMed ID: 20061053
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial.
Lajevardi V; Ghiasi M; Balighi K; Daneshpazhooh M; Azar PM; Kianfar N; Dasdar S; Peymanfar AA
Dermatol Ther; 2022 Nov; 35(11):e15868. PubMed ID: 36169160
[TBL] [Abstract][Full Text] [Related]
5. Platelet-rich plasma as a new and successful treatment for lichen planopilaris: A controlled blinded randomized clinical trial.
Behrangi E; Akbarzadehpasha A; Dehghani A; Zare S; Ghassemi M; Zeinali R; Goodarzi A; Lotfi Z
J Cosmet Dermatol; 2024 Mar; ():. PubMed ID: 38525908
[TBL] [Abstract][Full Text] [Related]
6. Treatment of lichen planopilaris with mycophenolate mofetil.
Tursen U; Api H; Kaya T; Ikizoglu G
Dermatol Online J; 2004 Jul; 10(1):24. PubMed ID: 15347506
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of mychophenolate mofetil in treating lichen planopilaris.
Azizpour A; Hatami P; Lajevardi V; Mohammadi M; Aryanian Z; Mohandesi NA
Dermatol Ther; 2022 Aug; 35(8):e15625. PubMed ID: 35674693
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris: a randomized controlled clinical trial.
Lajevardi V; Salarvand F; Ghiasi M; Nasimi M; Taraz M
J Dermatolog Treat; 2022 Mar; 33(2):769-773. PubMed ID: 32449418
[TBL] [Abstract][Full Text] [Related]
9. Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial.
Conrotto D; Carbone M; Carrozzo M; Arduino P; Broccoletti R; Pentenero M; Gandolfo S
Br J Dermatol; 2006 Jan; 154(1):139-45. PubMed ID: 16403107
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Review and Bayesian Network Meta-Analysis of Medical Therapies for Lichen Planopilaris.
Husein-ElAhmed H; Husein-ElAhmed S
Dermatology; 2024; 240(1):103-110. PubMed ID: 37852211
[TBL] [Abstract][Full Text] [Related]
11. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
[TBL] [Abstract][Full Text] [Related]
12. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial.
Lenane P; Macarthur C; Parkin PC; Krafchik B; DeGroot J; Khambalia A; Pope E
JAMA Dermatol; 2014 Jan; 150(1):47-50. PubMed ID: 24226568
[TBL] [Abstract][Full Text] [Related]
13. Clobetasol propionate--where, when, why?
Pels R; Sterry W; Lademann J
Drugs Today (Barc); 2008 Jul; 44(7):547-57. PubMed ID: 18806904
[TBL] [Abstract][Full Text] [Related]
14. Randomized, placebo-controlled, double-blind trial of clobetasol propionate 0.05% in the treatment of oral lichen planus.
Arduino PG; Campolongo MG; Sciannameo V; Conrotto D; Gambino A; Cabras M; Ricceri F; Carossa S; Broccoletti R; Carbone M
Oral Dis; 2018 Jul; 24(5):772-777. PubMed ID: 29297958
[TBL] [Abstract][Full Text] [Related]
15. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus.
Radfar L; Wild RC; Suresh L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb; 105(2):187-93. PubMed ID: 18230389
[TBL] [Abstract][Full Text] [Related]
16. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial.
Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI
Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil in erosive genital lichen planus: a case and review of the literature.
Deen K; McMeniman E
J Dermatol; 2015 Mar; 42(3):311-4. PubMed ID: 25583369
[TBL] [Abstract][Full Text] [Related]
18. Patient satisfaction after the treatment of vulvovaginal erosive lichen planus with topical clobetasol and tacrolimus: a survey study.
Jensen JT; Bird M; Leclair CM
Am J Obstet Gynecol; 2004 Jun; 190(6):1759-63; discussion 1763-5. PubMed ID: 15284791
[TBL] [Abstract][Full Text] [Related]
19. Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience.
Mardones F; Shapiro J
Clin Exp Dermatol; 2017 Oct; 42(7):755-759. PubMed ID: 28748570
[TBL] [Abstract][Full Text] [Related]
20. Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial.
Corrocher G; Di Lorenzo G; Mansueto P; Martinelli N; Esposito-Pellitteri M; Gelio S; Lombardo G; Pacor ML
Clin Ther; 2006 Sep; 28(9):1296-302. PubMed ID: 17062302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
